Assignee
HUDSON INST MED RES
AU·7 granted patents·11 pending applications·0 citations·filing 2016–2024
Top patents by PatentIndex Score
18 records- 0167US12448622B2OligonucleotidesHUDSON INST MED RES·Filed 2023·Granted Oct 21, 2025·0 cites·19 claims
- 0267US12384838B2CXCL10 binding proteins and uses thereofHUDSON INST MED RES·Filed 2023·Granted Aug 12, 2025·0 cites·5 claims
- 0366US2025243483A1OligonucleotidesHUDSON INST MED RES·Filed 2024·Application pending·0 cites
- 0460US2024350563A1Biotherapeutic enterococcus isolatesHUDSON INST MED RES·Filed 2022·Application pending·0 cites
- 0556US11725048B2CXCL10 binding proteins and compositions thereofHUDSON INST MED RES·Filed 2020·Granted Aug 15, 2023·0 cites·4 claims
- 0656US2024384268A1OligonucleotidesHUDSON INST MED RES·Filed 2022·Application pending·0 cites
- 0753US11046956B2Method of treatmentHUDSON INST MED RES·Filed 2019·Granted Jun 29, 2021·0 cites·8 claims
- 0853US2023110966A1Method of identifying microorganisms of a microbiomeHUDSON INST MED RES·Filed 2021·Application pending·0 cites
- 0952US2023348903A1OligonucleotidesHUDSON INST MED RES·Filed 2021·Application pending·0 cites
- 1049US2022127341A1A method for the treatment or prophylaxis of cancer by targeting the extracellular portion of keratin 14 (krt14) residing on cancer cellsHUDSON INST MED RES·Filed 2020·Application pending·0 cites
- 1139US2022008481A1Method of treatmentHUDSON INST MED RES·Filed 2021·Application pending·0 cites
- 1234US11230583B2Inhibin analogsHUDSON INST MED RES·Filed 2016·Granted Jan 25, 2022·0 cites·21 claims
- 1333US2019307811A1Method for treating airways diseaseHUDSON INST MED RES·Filed 2017·Application pending·0 cites
- 1433US2019204333A1Method of treatment and prognosisHUDSON INST MED RES·Filed 2016·Application pending·0 cites
- 1533US2022268780A1Methods of predicting endometrial receptivityHUDSON INST MED RES·Filed 2020·Application pending·0 cites
- 1631US2018092992A1Method of treatmentHUDSON INST MED RES·Filed 2016·Application pending·0 cites
- 1726US11590203B2Method of treatment ovarian cancerHUDSON INST MED RES·Filed 2018·Granted Feb 28, 2023·0 cites·18 claims
- 1823US11123376B2Method of treatmentHUDSON INST MED RES·Filed 2016·Granted Sep 21, 2021·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when HUDSON INST MED RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →